Impact of coronary artery stenting on the course of chronic kidney disease in patients with stable angina
- Authors: Iskenderov B.G.1, Zaitseva A.V1, Mozhzhukhin I.N1, Ivanchukova M.G1
-
Affiliations:
- Penza Institute for Postgraduate Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education
- Issue: Vol 29, No 13 (2022)
- Pages: 74-79
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/321134
- DOI: https://doi.org/10.18565/pharmateca.2022.13.74-79
- ID: 321134
Cite item
Open Access
Access granted
Abstract
Background. Comorbidity of cardiovascular diseases and kidney dysfunction is common in the population. Dueto the widespread introduction of interventional treatment of coronary artery disease (CAD), the study of the effect of myocardial revascularization on the prognosis of patients with chronic kidney disease (CKD) is of current importance. Objective. Evaluation of the effect of coronary artery stenting (CAS) on the course of CKD and analysis of cardiac events in patients with stable angina. Methods. 122 patients (80 men and 42 women) aged 54 to 67 years (mean age 60.5±6.4 years) with coronary artery disease in combination with stage 2 and 3a CKD were examined. Of these, 75 patients underwent CAS (Group 1), and 47 did not (Group 2). Clinical and instrumental examination was performed at baseline, 3 and 9 months after the start of the study. Patients underwent Doppler echocardiography, as well as assessment of the endothelium-dependent vasodilation, impaired local myocardial contractility, and exercise tolerance. Results. It was found that in patients with multivessel coronary artery lesions, the glomerular filtration rate (GFR) was lower on average by 29.7% (P<0.001), and the blood creatinine level was higher by 11.7% (P=0.013) than in patients with damage to one coronary artery. It was shown that in the 1st group, the implementation of CAS starting from the 3rd month after the procedure is accompanied by an improvement not only in hemodynamic parameters and an increase in exercise tolerance, but also by a significant increase in GFR and a decrease in the blood creatinine level. In addition, in the 1st group during the follow-up period, the development of acute coronary syndrome and the progression of CKD were detected much less frequently than in the 2nd group: 2.7 vs. 6.4% and 4.0 vs. 12.8%, respectively. Conclusion. Thus, in patients with stable angina and comorbid CKD, CAS improves the functional state of the kidneys and reduces the frequency of cardiac events.
Full Text
About the authors
Bakhram G. Iskenderov
Penza Institute for Postgraduate Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education
Email: iskenderovbg@mail.ru
Dr. Sci. (Med.), Professor at the Department of Therapy, Cardiology, Functional Diagnostics and Rheumatology Penza, Russia
A. V Zaitseva
Penza Institute for Postgraduate Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional EducationPenza, Russia
I. N Mozhzhukhin
Penza Institute for Postgraduate Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional EducationPenza, Russia
M. G Ivanchukova
Penza Institute for Postgraduate Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional EducationPenza, Russia
References
- Смирнов А.В., Ватазин А.В., Добронравов В.А. и др. Клинические рекомендации. Хроническая болезнь почек (ХБП). Нефрология. 2021; 25(5):10-82
- Sarnak M.J., Amann K., Bangalore S., et al. Chronic kidney disease and coronary artery disease. JACC. State-of-the-art review. JACC. 2019;74:1823-38. doi: 10.1016/j.jacc.2019.08.1017.
- Моисеев B.C., Мухин Н.А., Смирнов А.В. и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Клинические рекомендации. Российский кардиологический журнал. 2014;(8):7-37.
- Dan K, Miyoshi T., Nakahama M., et al. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein. Cardiorenal Med. 2018;8:151-59. doi: 10.1159/000486971
- Aoki T, Ishii H., Tanaka A., et al. Influence of chronic kidney disease and worsening renal function on clinical outcomes in patients undergoing primary percutaneous coronary intervention. Clin Exp Nephrol. 2019;23:182-88. doi: 10.1007/s10157-018-1622-y.
- Искендеров Б.Г, Сисина О.Н. Прогностическое значение дисфункции почек в ближайшем и отдаленном периоде после аортокоронарного шунтирования. Кардиология. 2015;11:73-8.
- Li Y., Hou X., Liu T., et al.Comparison of coronary artery bypass grafting and drug-eluting stent implantation in patients with chronic kidney disease: a propensity score matching study. Front Cardiovasc Med. 2022;9:802181. Doi: 10.3389/ fcvm.2022.802181.
- Charytan D.M., Natwick T., Solid C.A., et al.Comparative effectiveness of medical therapy, percutaneous revascularization, and surgical coronary revascularization in cardiovascular risk subgroups of patients with CKD: a retrospective cohort study of medicare beneficiaries. Am J Kidney Dis. 2019;74:463- 73. Doi: 10.1053/j. ajkd.2019.04.018.
- Se H.K., Cheol W.L., Sung-Cheol Y., et al. Coronary artery bypass grafting vs. drug-eluting stent implantation for multivessel disease in patients with chronic kidney disease. Korean Circ J. 2017;47:354-60. Doi: 10.4070/ kcj.2016.0439.
- Yamamoto K., Shiomi H., Morimoto T., et al. Percutaneous coronary intervention vs. coronary artery bypass grafting in patients with vs. without chronic kidney disease. Am J Cardiol. 2021;145:37-46. Doi: 10.1016/j. amjcard.2020.12.079.
- Wanha W., Kawecki D., Roleder T., et al. Longterm percutaneous coronary intervention outcomes of patients with chronic kidney disease in the era of second-generation drug-eluting stents. Cardiorenal Med. 2017;7:85-95. doi: 10.1159/000452745.
- Murata N., Kaneko H., Yajima J., et al. The prognostic impact of worsening renal function in Japanese patients undergoing percutaneous coronary intervention with acute coronary syndrome. J Cardiol. 2015;66:326-32. doi: 10.1016/j.jjcc.2014.12.005.
- Zhang J., Bottiglieri T., McCullough PA. The central role of endothelial dysfunction in cardiorenal syndrome. Cardiorenal Med. 2017;7:104-17. doi: 10.1159/000452283.
- Papachristidis A., Lim W.Y., Voukalis C., et al. Determinants of mortality in patients with chronic kidney disease undergoing percutaneous coronary intervention. Cardiorenal Med. 2016;6:169-79. doi: 10.1159/000442897.
- Wei X., Zhang Y., Yan G., Wang X. The Relationship Between Chronic Kidney Disease and the Severity and Long-Term Prognosis of Patients with Coronary Artery Disease After Drug-Eluting Stent Implantation.Int J Gen Med. 2021;14:399-404. Doi: 10.2147/ IJGM.S295098.
Supplementary files
